{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-000087","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.407274+00:00","generated_at":"2026-05-28T00:58:42.663160+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Lexaria shareholders re-elect all directors; McKechnie gets 54% support, Baxter 62%","bullets":["Annual meeting on Jan 14, 2025: 9,761,279 shares (55.93% of outstanding) represented.","Directors elected: Bunka 89%, Docherty 98%, Baxter 62%, McKechnie 54%, Reese 90%, Christopher 98%, Bhullar 98%.","Say-on-pay frequency approved every three years with 66% of votes cast; advisory compensation passed at 97%.","Warrant exercise proposal approved by 70% of votes cast; auditor Malone Bailey LLP ratified with 98%."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-000087","json":"https://secwatch.observer/filing/0001640334-25-000087.json","markdown":"https://secwatch.observer/filing/0001640334-25-000087.md","text":"https://secwatch.observer/filing/0001640334-25-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/0001640334-25-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425000087/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:58:42.663160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}